Michelle is a highly experienced transactional IP specialist. Michelle provides strategic and transactional IP advice to clients in a wide range of sectors and has specific expertise within the pharmaceutical and life sciences sector having worked 12 years with AstraZeneca and with a BSc in Pharmacology & Physiology.
Michelle is experienced in the drafting and negotiation of a whole range of agreements including licensing, co-development, clinical, manufacture, services and supply contracts and has provided IP advice on a number of major corporate licensing transactions, acquisitions and business sales and works regularly with many educational institutions and their spin-out companies.
In addition to her expertise in the life sciences sector, Michelle also advises clients within the retail sector in connection with brand licensing, digital content arrangements, data privacy, website development, commercial terms of business, distribution, supply and franchising.
Michelle regularly presents on a broad range of IP and commercial topics including licensing, strategic IP protection and GDPR. Michelle has also delivered a range of legal training focused towards compliance programmes within in-house teams, including on topics such as Good Document Practice, Handling Sensitive Information, Alliance & Post-Deal Management, Market Disclosure & Insider Trading and Issue Management Team Set-Up & Support. Michelle sits on a University Ethics Committee for the review of life sciences projects and is a member of the Licensing Executives Society and Pharmaceutical Licensing Group.
England & Wales
Dual Hons in Pharmacology & Physiology
Post Graduate Diploma in Law (CPE)
Post Graduate Diploma in Legal Practice (LPC)
‘I find Michelle Davies is easy to dialogue with, listens, advises and gently steers well.’
January 27th 2021
January 14th 2021
December 3rd 2020
December 1st 2020
October 15th 2020
July 29th 2020
July 29th 2020
June 9th 2020
December 3rd 2019
November 26th 2019
November 26th 2019
September 24th 2019
January 1st 1970
Michelle sits on the Leeds University Biological Sciences Ethics Committee for the review of life sciences projects and she is a member of the Licensing Executives Society and Pharmaceutical Licensing Group.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
HGF and British-Swiss Chamber of Commerce are holding a webinar on 10th May 2021. Join HGF Partner and Patent Attorney Mike Nelson and Michaël Alder, Legal Advisor at the Swiss Federal Institute of …Event details
The AWRC Wellbeing Accelerator supports start-ups, academics and businesses working in wellbeing with mentoring, sector expertise and specialist facilities. HGF Partner Vanessa Stainthorpe will be running a workshop on 26th April. She …Event details
WIPR and HGF are holding a webinar on 9th March. HGF Partner Dr Susan Keston and Patent Director Dr Lauris Kemp will be presenting a webinar on 9th March on ‘Applied AI: Effectively …Event details
HGF is attending IQPC Global IP Exchange Europe 2021 virtual event being held 9 – 10 March 2021. The Global IP Exchange exclusively brings together 90 expert Chief IP Counsel, Heads and …Event details
KTN Microbiome Strategic Roadmap is now live. The roadmap reviews the landscape of microbiome science and innovation within the UK. The main objective of this document is to raise the visibility of …Read article
In 2021, HGF will be delivering its 8th Annual IP in Retail Conference differently. As usual, we have put together an agenda which considers topical IP issues encountered by in-house …Event details
Blockchain is still a buzzword but how can it help in the business of combatting the problem of counterfeit goods? Firstly, what is Blockchain? Blockchain has been around as concept …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.